GLAXOSMITHKLINE jobs in DURHAM NC DURHAM, United Kingdom

Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring... their HIV assets to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...

ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to bei...

We are looking for a Commercial Analytics Manager to join our U.S. Pharma Commercial Insights team, with a focus on the specialty business unit. This role requires strong data analytics experience, familiarity with connecting analytics to b...

In office 2-3 times per week Company Overview ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare ...

Are you energized by the challenge of accelerating a procurement organization at a biopharma company that cares about being ambitious for patients, while being accountable for impact and doing the right thing? If so, this Procurement Manage...

In office 2-3 times per week Company Overview ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare ...

Does a role as a medical affairs business leader, involved in shaping the US launch excellence pathway for multiple specialty assets, sound exciting to you? As Scientific Director, Specialty Pipeline you will use your clinical and scienti...

ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to bei...

Purpose: Ensure the development of appropriate regulatory strategy(ies) and their execution for for early and/or late stage HIV or other assigned asset(s) consistent with Medicines Development Strategy/Integrated Asset Plan (IAP). This go...